Business Description
Metagenomi Therapeutics Inc. is a California-based company focused on developing gene-editing treatments that aim to permanently correct the underlying causes of serious diseases. Its lead program targets hemophilia, seeking to protect patients from dangerous bleeding episodes and long-term joint damage. The company also works with Ionis Pharmaceuticals on several programs addressing conditions such as high triglycerides, a rare protein-buildup disorder, and difficult-to-treat high blood pressure. Founded in 2016 and based in Emeryville, California, the company operates exclusively in the United States.
